Martin Dutertre

Dr. Martin Dutertre

Institut Curie – Centre De Recherche, Rue Henri Becquerel, 91401 ORSAY Cedex, France
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2016 in Nature Communications
Verified
Journal Article
Open access
SASamar Alsafadi
Samar Alsafadi
AHAlexandre Houy
Alexandre Houy
ABAude Battistella
Aude Battistella
TPTatiana Popova
Tatiana Popova
MWMichel Wassef
Michel Wassef
MSMarc-Henri Stern
Marc-Henri Stern
Hotspot mutations in the spliceosome gene SF3B1 are reported in ∼20% of uveal melanomas. SF3B1 is involved in 3′-splice site (3′ss) recognition during RNA splicing; however, the molecular mechanisms of its mutation have remained unclear. Here we show, using RNA-Seq analyses of uveal melanoma, that the SF3B1R625/K666 mutation results in deregulated splicing at a subset of junctions, mostly by the use of alternative 3′ss. Modelling the differential junctions in SF3B1WT and SF3B1R625/K666 cell lines demonstrates that the deregulated splice pattern strictly depends on SF3B1 status and on the 3’ss-sequence context. SF3B1WT knockdown or overexpression do not reproduce the SF3B1R625/K666 splice pattern, qualifying SF3B1R625/K666 as change-of-function mutants. Mutagenesis of predicted branchpoints reveals that the SF3B1R625/K666-promoted splice pattern is a direct result of alternative branchpoint usage. Altogether, this study provides a better understanding of the mechanisms underlying splicing alterations induced by mutant SF3B1 in cancer, and reveals a role for alternative branchpoints in disease.

30 November 2000 in Nature Cell Biology
Verified
Journal Article
Closed access
DSDavid L. Stenoien
David L. Stenoien
KPKavita Patel
Kavita Patel
MMMaureen G. Mancini
Maureen G. Mancini
Martin DutertreMartin Dutertre
Martin Dutertre
CSCarolyn L. Smith
Carolyn L. Smith
MMMichael A. Mancini
Michael A. Mancini

1 June 2014 in Cell Reports
Verified
Journal Article
Open access
EDEtienne Dardenne
Etienne Dardenne
MEMicaela Polay Espinoza
Micaela Polay Espinoza
LFLaurent Fattet
Laurent Fattet
SGSophie Germann
Sophie Germann
MLMarie-Pierre LAMBERT
Marie-Pierre LAMBERT
Didier AuboeufDidier Auboeuf
Didier Auboeuf
The RNA helicases DDX5 and DDX17 are members of a large family of highly conserved proteins that are involved in gene-expression regulation; however, their in vivo targets and activities in biological processes such as cell differentiation, which requires reprogramming of gene-expression programs at multiple levels, are not well characterized. Here, we uncovered a mechanism by which DDX5 and DDX17 cooperate with heterogeneous nuclear ribonucleoprotein (hnRNP) H/F splicing factors to define epithelial- and myoblast-specific splicing subprograms. We then observed that downregulation of DDX5 and DDX17 protein expression during myogenesis and epithelial-to-mesenchymal transdifferentiation contributes to the switching of splicing programs during these processes. Remarkably, this downregulation is mediated by the production of miRNAs induced upon differentiation in a DDX5/DDX17-dependent manner. Since DDX5 and DDX17 also function as coregulators of master transcriptional regulators of differentiation, we propose to name these proteins "master orchestrators" of differentiation that dynamically orchestrate several layers of gene expression.

15 September 1997 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LAL Al-Attar
L Al-Attar
KNK Noël
K Noël
Martin DutertreMartin Dutertre
Martin Dutertre
CBCorinne Belville
Corinne Belville
MFM G Forest
M G Forest
RRR Rey
R Rey
Anti-Müllerian hormone (AMH) is secreted by immature testicular Sertoli cells. Clinical studies have demonstrated a negative correlation between serum AMH and testosterone in puberty but not in the neonatal period. We investigated AMH regulation using mouse models mimicking physiopathological situations observed in humans. In normal mice, intratesticular, not serum, testosterone repressed AMH synthesis, explaining why AMH is downregulated in early puberty when serum testosterone is still low. In neonatal mice, AMH was not inhibited by intratesticular testosterone, due to the lack of expression of the androgen receptor in Sertoli cells. We had shown previously that androgen-insensitive patients exhibit elevated AMH in coincidence with gonadotropin activation. In immature normal and in androgen-insensitive Tfm mice, follicle stimulating hormone (FSH) administration resulted in elevation of AMH levels, indicating that AMH secretion is stimulated by FSH in the absence of the negative effect of androgens. The role of meiosis on AMH expression was investigated in Tfm and in pubertal XXSxrb mice, in which germ cells degenerate before meiosis. We show that meiotic entry acts in synergy with androgens to inhibit AMH. We conclude that AMH represents a useful marker of androgen and FSH action within the testis, as well as of the onset of meiosis.

1 November 2000 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
Martin DutertreMartin Dutertre
Martin Dutertre
CSCarolyn L. Smith
Carolyn L. Smith

24 October 2010 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
Martin DutertreMartin Dutertre
Martin Dutertre
GSGabriel Sanchez
Gabriel Sanchez
MCMarie-Cécile De Cian
Marie-Cécile De Cian
JBJérôme Barbier
Jérôme Barbier
EDEtienne Dardenne
Etienne Dardenne
Didier AuboeufDidier Auboeuf
Didier Auboeuf